B. Kressel

Early clinical recognition of disseminated candidiasis by muscle and skin biopsy.

C. Tuazon, B. Kressel, C. Szewczyk, 1978, Archives of internal medicine.

Detection fidelity of AR mutations in plasma derived cell-free DNA

B. Trock, E. Antonarakis, B. Park, 2017, Oncotarget.

Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma

P. Schein, J. Berenberg, K. Ryan, 1981, Cancer.

ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.

M. Rubin, J. Hainsworth, V. Miller, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer

B. Trock, E. Antonarakis, B. Park, 2019, JCO precision oncology.

Periostitis associated with myelofibrosis

B. Mason, G. Schechter, A. Bernath, 1979, Cancer.

Disseminated intravascular coagulation in an ambulatory young woman.

M. Horne, B. Kressel, G. Aue, 2005, The Journal of laboratory and clinical medicine.

A Case of Complete and Durable Molecular Remission of Chronic Lymphocytic Leukemia Following Treatment with Epigallocatechin-3-gallate, an Extract of Green Tea

V. Sukhatme, D. Lemanne, K. Block, 2015, Cureus.

Biomarker Analyses from a Randomized, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab with or without Erlotinib as Maintenance Therapy for the Treatment of Advanced Non-Small-Cell Lung Cancer (ATLAS)

J. Hainsworth, V. Miller, F. Kabbinavar, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Case Report and Brief Review

J. A. Fox, B. Kressel, J. E. Granato, 2015 .

Micro a ng iopa th ic Hem o lytic Anemia, 7h ro m bo cytopen ia, and Renal Failure in Patients Treated for Adenocarcinoma

J. Berenberg, K. Ryan, B. Kressel, 1981 .